Cytocidal etfect of high energy shock wave on tumour cells enhanced with larger dose and multiple exposures

C. Z. Yao; J. Ishizuka; R. J. Bold; C. M. Townsend; J. C. Thompson

doi:10.1016/0960-7404(94)90038-8

Cytocidal etfect of high energy shock wave on tumour cells enhanced with larger dose and multiple exposures

C. Z. Yao, J. Ishizuka, R. J. Bold, C. M. Townsend, J. C. Thompson

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

Cultured LLC-WRC256 (Walker rat carcinoma) cells were exposed to different doses of high energy shock waves (HESW). The immediate viabilities were 98% in the control cells, and 74%, 53% and 18% following 400, 800, and 1500 HESW treatment, respectively. Surviving cells in the 400 and 800-treated HESW demonstrated delayed upward growth rate curves, and the 1500 HESW-treated a downward curve. Agar clonogenic etficiencies for surviving cells were 36% (control), 20% (400 HESW), 15% (800 HESW) and 3% (1500 HESW). LLC-WRC256 tumours in Wistar rats were treated once every other day with 1500 HESW on a total of three occasions. Tumours treated with HESW grew more slowly (4.9 cm³) than those in the control (13.5 cm³). HESW fragmented cells and destroyed cell membranes and intracellular organelles. A histological examination of tumours treated with HESW demonstrated local haemorrhage with necrosis in the HESW focus area. Damage to the surrounding skin and soft tissue was slight and transient. These findings suggest that the growth of tumour cells can be suppressed in vitro and in vivo by treatment with HESW.

Original language	English (US)
Pages (from-to)	229-235
Number of pages	7
Journal	Surgical oncology
Volume	3
Issue number	4
DOIs	https://doi.org/10.1016/0960-7404(94)90038-8
State	Published - Aug 1994
Externally published	Yes

Keywords

LLC-WRC 256
clonogenic efficiency
high energy shock wave (HESW)

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1016/0960-7404(94)90038-8

Cite this

@article{2d7b05eef6a2428f81a64b9bae5e1691,

title = "Cytocidal etfect of high energy shock wave on tumour cells enhanced with larger dose and multiple exposures",

abstract = "Cultured LLC-WRC256 (Walker rat carcinoma) cells were exposed to different doses of high energy shock waves (HESW). The immediate viabilities were 98% in the control cells, and 74%, 53% and 18% following 400, 800, and 1500 HESW treatment, respectively. Surviving cells in the 400 and 800-treated HESW demonstrated delayed upward growth rate curves, and the 1500 HESW-treated a downward curve. Agar clonogenic etficiencies for surviving cells were 36% (control), 20% (400 HESW), 15% (800 HESW) and 3% (1500 HESW). LLC-WRC256 tumours in Wistar rats were treated once every other day with 1500 HESW on a total of three occasions. Tumours treated with HESW grew more slowly (4.9 cm3) than those in the control (13.5 cm3). HESW fragmented cells and destroyed cell membranes and intracellular organelles. A histological examination of tumours treated with HESW demonstrated local haemorrhage with necrosis in the HESW focus area. Damage to the surrounding skin and soft tissue was slight and transient. These findings suggest that the growth of tumour cells can be suppressed in vitro and in vivo by treatment with HESW.",

keywords = "LLC-WRC 256, clonogenic efficiency, high energy shock wave (HESW)",

author = "Yao, {C. Z.} and J. Ishizuka and Bold, {R. J.} and Townsend, {C. M.} and Thompson, {J. C.}",

note = "Funding Information: This work was supported by grants from The American Cancer Society (CB-571) and The National Institutes of Health (5R37DK15241-23 and 5POl DK356-08).",

year = "1994",

month = aug,

doi = "10.1016/0960-7404(94)90038-8",

language = "English (US)",

volume = "3",

pages = "229--235",

journal = "Surgical oncology",

issn = "0960-7404",

publisher = "Elsevier Ltd",

number = "4",

}

TY - JOUR

T1 - Cytocidal etfect of high energy shock wave on tumour cells enhanced with larger dose and multiple exposures

AU - Yao, C. Z.

AU - Ishizuka, J.

AU - Bold, R. J.

AU - Townsend, C. M.

AU - Thompson, J. C.

N1 - Funding Information: This work was supported by grants from The American Cancer Society (CB-571) and The National Institutes of Health (5R37DK15241-23 and 5POl DK356-08).

PY - 1994/8

Y1 - 1994/8

N2 - Cultured LLC-WRC256 (Walker rat carcinoma) cells were exposed to different doses of high energy shock waves (HESW). The immediate viabilities were 98% in the control cells, and 74%, 53% and 18% following 400, 800, and 1500 HESW treatment, respectively. Surviving cells in the 400 and 800-treated HESW demonstrated delayed upward growth rate curves, and the 1500 HESW-treated a downward curve. Agar clonogenic etficiencies for surviving cells were 36% (control), 20% (400 HESW), 15% (800 HESW) and 3% (1500 HESW). LLC-WRC256 tumours in Wistar rats were treated once every other day with 1500 HESW on a total of three occasions. Tumours treated with HESW grew more slowly (4.9 cm3) than those in the control (13.5 cm3). HESW fragmented cells and destroyed cell membranes and intracellular organelles. A histological examination of tumours treated with HESW demonstrated local haemorrhage with necrosis in the HESW focus area. Damage to the surrounding skin and soft tissue was slight and transient. These findings suggest that the growth of tumour cells can be suppressed in vitro and in vivo by treatment with HESW.

AB - Cultured LLC-WRC256 (Walker rat carcinoma) cells were exposed to different doses of high energy shock waves (HESW). The immediate viabilities were 98% in the control cells, and 74%, 53% and 18% following 400, 800, and 1500 HESW treatment, respectively. Surviving cells in the 400 and 800-treated HESW demonstrated delayed upward growth rate curves, and the 1500 HESW-treated a downward curve. Agar clonogenic etficiencies for surviving cells were 36% (control), 20% (400 HESW), 15% (800 HESW) and 3% (1500 HESW). LLC-WRC256 tumours in Wistar rats were treated once every other day with 1500 HESW on a total of three occasions. Tumours treated with HESW grew more slowly (4.9 cm3) than those in the control (13.5 cm3). HESW fragmented cells and destroyed cell membranes and intracellular organelles. A histological examination of tumours treated with HESW demonstrated local haemorrhage with necrosis in the HESW focus area. Damage to the surrounding skin and soft tissue was slight and transient. These findings suggest that the growth of tumour cells can be suppressed in vitro and in vivo by treatment with HESW.

KW - LLC-WRC 256

KW - clonogenic efficiency

KW - high energy shock wave (HESW)

UR - http://www.scopus.com/inward/record.url?scp=0027939253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027939253&partnerID=8YFLogxK

U2 - 10.1016/0960-7404(94)90038-8

DO - 10.1016/0960-7404(94)90038-8

M3 - Article

C2 - 7834114

AN - SCOPUS:0027939253

SN - 0960-7404

VL - 3

SP - 229

EP - 235

JO - Surgical oncology

JF - Surgical oncology

IS - 4

ER -

Cytocidal etfect of high energy shock wave on tumour cells enhanced with larger dose and multiple exposures

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this